Cargando…
Four Days Are Enough to Provide a Reliable Daily Step Count in Mild to Moderate Parkinson’s Disease through a Commercial Smartwatch
Daily steps could be a valuable indicator of real-world ambulation in Parkinson’s disease (PD). Nonetheless, no study to date has investigated the minimum number of days required to reliably estimate the average daily steps through commercial smartwatches in people with PD. Fifty-six patients were m...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649244/ https://www.ncbi.nlm.nih.gov/pubmed/37960670 http://dx.doi.org/10.3390/s23218971 |
_version_ | 1785135521864876032 |
---|---|
author | Bianchini, Edoardo Galli, Silvia Alborghetti, Marika De Carolis, Lanfranco Zampogna, Alessandro Hansen, Clint Vuillerme, Nicolas Suppa, Antonio Pontieri, Francesco E. |
author_facet | Bianchini, Edoardo Galli, Silvia Alborghetti, Marika De Carolis, Lanfranco Zampogna, Alessandro Hansen, Clint Vuillerme, Nicolas Suppa, Antonio Pontieri, Francesco E. |
author_sort | Bianchini, Edoardo |
collection | PubMed |
description | Daily steps could be a valuable indicator of real-world ambulation in Parkinson’s disease (PD). Nonetheless, no study to date has investigated the minimum number of days required to reliably estimate the average daily steps through commercial smartwatches in people with PD. Fifty-six patients were monitored through a commercial smartwatch for 5 consecutive days. The total daily steps for each day was recorded and the average daily steps was calculated as well as the working and weekend days average steps. The intraclass correlation coefficient (ICC) (3,k), standard error of measurement (SEM), Bland–Altman statistics, and minimum detectable change (MDC) were used to evaluate the reliability of the step count for every combination of 2–5 days. The threshold for acceptability was set at an ICC ≥ 0.8 with a lower bound of CI 95% ≥ 0.75 and a SAM < 10%. ANOVA and Mann–Whitney tests were used to compare steps across the days and between the working and weekend days, respectively. Four days were needed to achieve an acceptable reliability (ICC range: 0.84–0.90; SAM range: 7.8–9.4%). In addition, daily steps did not significantly differ across the days and between the working and weekend days. These findings could support the use of step count as a walking activity index and could be relevant to developing monitoring, preventive, and rehabilitation strategies for people with PD. |
format | Online Article Text |
id | pubmed-10649244 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106492442023-11-04 Four Days Are Enough to Provide a Reliable Daily Step Count in Mild to Moderate Parkinson’s Disease through a Commercial Smartwatch Bianchini, Edoardo Galli, Silvia Alborghetti, Marika De Carolis, Lanfranco Zampogna, Alessandro Hansen, Clint Vuillerme, Nicolas Suppa, Antonio Pontieri, Francesco E. Sensors (Basel) Article Daily steps could be a valuable indicator of real-world ambulation in Parkinson’s disease (PD). Nonetheless, no study to date has investigated the minimum number of days required to reliably estimate the average daily steps through commercial smartwatches in people with PD. Fifty-six patients were monitored through a commercial smartwatch for 5 consecutive days. The total daily steps for each day was recorded and the average daily steps was calculated as well as the working and weekend days average steps. The intraclass correlation coefficient (ICC) (3,k), standard error of measurement (SEM), Bland–Altman statistics, and minimum detectable change (MDC) were used to evaluate the reliability of the step count for every combination of 2–5 days. The threshold for acceptability was set at an ICC ≥ 0.8 with a lower bound of CI 95% ≥ 0.75 and a SAM < 10%. ANOVA and Mann–Whitney tests were used to compare steps across the days and between the working and weekend days, respectively. Four days were needed to achieve an acceptable reliability (ICC range: 0.84–0.90; SAM range: 7.8–9.4%). In addition, daily steps did not significantly differ across the days and between the working and weekend days. These findings could support the use of step count as a walking activity index and could be relevant to developing monitoring, preventive, and rehabilitation strategies for people with PD. MDPI 2023-11-04 /pmc/articles/PMC10649244/ /pubmed/37960670 http://dx.doi.org/10.3390/s23218971 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bianchini, Edoardo Galli, Silvia Alborghetti, Marika De Carolis, Lanfranco Zampogna, Alessandro Hansen, Clint Vuillerme, Nicolas Suppa, Antonio Pontieri, Francesco E. Four Days Are Enough to Provide a Reliable Daily Step Count in Mild to Moderate Parkinson’s Disease through a Commercial Smartwatch |
title | Four Days Are Enough to Provide a Reliable Daily Step Count in Mild to Moderate Parkinson’s Disease through a Commercial Smartwatch |
title_full | Four Days Are Enough to Provide a Reliable Daily Step Count in Mild to Moderate Parkinson’s Disease through a Commercial Smartwatch |
title_fullStr | Four Days Are Enough to Provide a Reliable Daily Step Count in Mild to Moderate Parkinson’s Disease through a Commercial Smartwatch |
title_full_unstemmed | Four Days Are Enough to Provide a Reliable Daily Step Count in Mild to Moderate Parkinson’s Disease through a Commercial Smartwatch |
title_short | Four Days Are Enough to Provide a Reliable Daily Step Count in Mild to Moderate Parkinson’s Disease through a Commercial Smartwatch |
title_sort | four days are enough to provide a reliable daily step count in mild to moderate parkinson’s disease through a commercial smartwatch |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649244/ https://www.ncbi.nlm.nih.gov/pubmed/37960670 http://dx.doi.org/10.3390/s23218971 |
work_keys_str_mv | AT bianchiniedoardo fourdaysareenoughtoprovideareliabledailystepcountinmildtomoderateparkinsonsdiseasethroughacommercialsmartwatch AT gallisilvia fourdaysareenoughtoprovideareliabledailystepcountinmildtomoderateparkinsonsdiseasethroughacommercialsmartwatch AT alborghettimarika fourdaysareenoughtoprovideareliabledailystepcountinmildtomoderateparkinsonsdiseasethroughacommercialsmartwatch AT decarolislanfranco fourdaysareenoughtoprovideareliabledailystepcountinmildtomoderateparkinsonsdiseasethroughacommercialsmartwatch AT zampognaalessandro fourdaysareenoughtoprovideareliabledailystepcountinmildtomoderateparkinsonsdiseasethroughacommercialsmartwatch AT hansenclint fourdaysareenoughtoprovideareliabledailystepcountinmildtomoderateparkinsonsdiseasethroughacommercialsmartwatch AT vuillermenicolas fourdaysareenoughtoprovideareliabledailystepcountinmildtomoderateparkinsonsdiseasethroughacommercialsmartwatch AT suppaantonio fourdaysareenoughtoprovideareliabledailystepcountinmildtomoderateparkinsonsdiseasethroughacommercialsmartwatch AT pontierifrancescoe fourdaysareenoughtoprovideareliabledailystepcountinmildtomoderateparkinsonsdiseasethroughacommercialsmartwatch |